Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Patients' app diagnoses 'not useful'

More patients are going to their GP and telling them what treatment they need based on information from apps and the internet, a survey has suggested. A third of the UK physicians surveyed said patients would come with suggestions for what prescription they should receive, but fewer than 5% of doctors felt it was helpful.

Published
02 October 2014
From
BBC
Thai patients to receive free HIV drugs, regardless of CD4 count

The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.

Published
02 October 2014
From
Bangkok Post
Advocates Applaud Launch of MTN-017, World’s First Phase II Rectal Microbicide Study

IRMA applauds the launch of the world’s first-ever Phase II rectal microbicide trial. The Microbicide Trial Network’s study, called MTN-017, will test a reduced glycerin formulation of tenofovir gel applied rectally. Volunteers consisting of gay men, other men who have sex with men, and transgender women will participate in the study at sites in the United States and in Thailand, South Africa, and Peru.

Published
02 October 2014
From
IRMA
Morocco's quiet revolution over AIDS and human rights

Morocco's human rights landscape is evolving for a number of reasons, many of which could have a positive effect on the way the country responds to its HIV epidemic. The right to access health services, the right to respect for human dignity, the right to discretion and privacy: all are becoming normative in the traditionally conservative Kingdom, which was among the only countries in the region that did not experience any upheaval during the Arab Spring.

Published
02 October 2014
From
Aidspan
The Impact of Faith-Based Organisations on Public Health and Social Capital

As a network of faith-based organisations, FaithAction knows that there are many faith groups up and down the country doing health-related work in their communities. However, the value of this work is in danger of not being recognised, both by the groups themselves and by policymakers, in large part because there is a lack of evidence around what is taking place and its effectiveness.

Published
01 October 2014
From
Faith Action
Treatment Action Campaign faces closure

After almost two decades spent fighting for HIV treatment and access to medicines, the Treatment Action Campaign (TAC) may close its doors due to a severe funding shortage.

Published
01 October 2014
From
Health-e
Europe: Pharma industry denies it lobbied for medicines to move to DG Enterprise

Europe’s pharmaceutical industry has said it did not lobby for medicines and medical devices to be moved from the European Commission's health directorate (DG Sanco) to the enterprise directorate (DG Enterprise).

Published
01 October 2014
From
EurActiv
Exclusive: India set to run out of critical free drug for HIV/AIDS program

India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month.

Published
01 October 2014
From
Reuters
J&J makes a splash in hep C with a $1.75B deal for Alios

Johnson & Johnson ($JNJ) is taking a deep dive into antivirals, trading $1.75 billion for private biotech Alios BioPharma to get its hands on a midstage treatment and some early assets that could expand its share of the blockbuster hepatitis C market.

Published
01 October 2014
From
Fierce Biotech
France uses tax to put pressure on hepatitis C drug prices

France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

Published
01 October 2014
From
Reuters

Filter by country